Recombinant Human PTPN4 Protein，His

PTPN4, also known as Protein Tyrosine Phosphatase Non-Receptor Type 4, is a member of the protein tyrosine phosphatase family, which plays a crucial role in various cellular processes by regulating tyrosine phosphorylation levels. This regulation influences signaling pathways related to cell growth, differentiation, and immune response. Recent studies have highlighted the involvement of PTPN4 in multiple diseases, including cancer, where its expression levels can significantly affect tumor progression and metastasis. Additionally, PTPN4 has been implicated in autoimmune disorders, suggesting its potential role in modulating immune responses. Researchers are increasingly interested in recombinant PTPN4 for its therapeutic potential, as understanding its structure and function may lead to the development of targeted treatments that can modulate its activity. The generation of recombinant PTPN4 allows for in-depth functional studies, enzymatic assays, and structural analysis, providing insights into its mechanism of action. Recent advancements in recombinant protein technology have made it feasible to produce PTPN4 in heterologous systems, facilitating the study of its properties and interactions at a molecular level. These findings not only enhance our understanding of PTPN4's biological roles but also pave the way for potential applications in precision medicine aimed at diseases where PTPN4 is deregulated. Continued investigation into PTPN4 could reveal novel therapeutic targets and strategies for diseases characterized by altered tyrosine phosphorylation, making it a protein of significant interest in biomedical research.